腹部肿瘤放射性粒子植入并发症处理及预防
Prevention and treatment of complications of abdominal tumor by radioactive seeds implantation

DOI: 10.6040/j.issn.1671-7554.0.2016.1477

Keywords: 腹部肿瘤,并发症,放射性粒子,
Complications,Radioactive seeds,Abdominal tumor

Full-Text   Cite this paper   Add to My Lib

Abstract:

References

[1]	姚红响, 陈根生, 徐磊, 等. CT引导下同轴法<sup>125</sup>I粒子植入治疗腹膜后淋巴结转移瘤21例[J]. 介入放射学杂志, 2014, 23(1): 42-45. YAO Hongxiang, CHEN Gensheng, XU Lei, et al. CT-guide coaxial <sup>125</sup>I seeds implantation for the treatment of retroperltoneal lymph node metastasis: analysis of 21 cases[J]. Journal of Interventional Radiology, 2014, 23(1): 42-45.
[2]	易福梅, 王皓, 袁慧书, 等. CT引导<sup>125</sup>I放射性粒子植入治疗局部复发性直肠癌的疗效分析[J]. 中华放射医学与防护杂志, 2014, 34(1): 30-33. YI Fumei, WANG Hao, YUAN Huishu, et al. CT-guided <sup>125</sup>I radioactive seed implantation for locally recurrent rectal cancer[J]. Chinese Journal of Radiological Medicine and Protection, 2014, 34(1): 30-33.
[3]	Yoshida K, Ohashi T, Yorozu A, et al. Comparison of preplanning and intraoperative planning for <sup>125</sup>I prostate brachytherapy[J]. Jpn J Clin Oncol, 2013, 43(4): 383-389.
[4]	刘健, 张福君, 吴沛宏, 等. CT导向下<sup>125</sup>I粒子植入治疗肝门区肝癌[J]. 介入放射学杂志, 2005, 14(6): 606-609. LIU Jian, ZHANG Fujun, WU Peihong, et al. CT-guided radioactive seed <sup>125</sup>I implantation in treating hilar hepatic tumor and metastatic lymph nodes[J]. Journal of Interventional Radiology, 2005, 14(6): 606-609.
[5]	姜涛,王大光,王国良,等.泌尿系恶性肿瘤患者手术联合 DC-CIK免疫细胞治疗安全性临床研究[J].中华临床医师杂志,2015, 9(12): 2327-2330. JIANG Tao, WANG Daguang, WANG Guoliang, et al. Security of clinical research in urological cancer patients after surgery combined DC-CIK cells immunotherapy treatment[J]. Journal of Clinical Physicians, 2015, 9(12): 2327-2330.
[6]	Liu B, ZHhou T, Geng J, et al. Percutaneous computed tomography-guided iodine-125 seeds implantation for unresectable pancreas[J]. Indian J Cancer, 2015, 52(2): 69-74.
[7]	于聪慧, 姚军波, 杨荣华, 等. <sup>125</sup>I放射性粒子植入治疗晚期胰腺癌26例临床分析[J]. 国际外科学杂志, 2014, 41(9): 614-617. YU Conghui, YAO Junbo, YANG Ronghua, et al. Clinical analysis of <sup>125</sup>I radioactive seeds implantation treatment in 26 cases of advanced pancreatic cancer[J]. International Journal of Surgery, 2014, 41(9): 614-617.
[8]	黄洪军, 江勇, 吴宝强, 等. 术中<sup>125</sup>I放射性粒子植入治疗不能切除晚期胰腺癌的并发症和预后分析[J]. 肝胆胰外科杂志, 2014, 26(4): 281-284. HUANG Hongjun, JIANG Yong, WU Baoqing, et al. Complications and prognosis of intraoperative iodine-125 seed implantation therapy in patients with unresectable advanced pancreatic cancer[J]. Journal of Hepatopancreatobiliary Surgery, 2014, 26(4): 281-284.
[9]	沈新颖, 张彦舫, 窦永充, 等. <sup>125</sup>I粒子 CT导向植入治疗恶性肿瘤多发腹膜后淋巴结转移[J]. 放射学实践, 2012, 27(10): 1128-1131. SHEN Xinying, ZHANG Yanfang, DOU Yongchong, et al. CT-guided <sup>125</sup>I seeds implantation for the treatment of multiple retroperitoneal lymph node metastases of malignant neoplasm[J]. Radiologic Practice, 2012, 27(10): 1128-1131.
[10]	Lin L, Wang J, Jiang Y, et al. Interstitial <sup>125</sup>I seed implantation for cervical lymph node recurrence after multimodal treatment of thoracic esophageal squamous cell carcinoma[J]. Technol Cancer Res Treat, 2015, 14(2): 201-207.
[11]	王娟, 隋爱霞, 赵静, 等. CT引导下经胃入路<sup>125</sup>I粒子治疗腹膜后转移癌10例[J]. 介入放射学杂志, 2015, 24(8): 698-701. WANG Juan, SUI Aixia, ZHAO Jing, et al. CT guided <sup>125</sup>I brachytherapy via transgastric approach for the treatment of retroperitoneal metastases: initial experience in 10 cases[J]. Journal of Interventional Radiology, 2015, 24(8): 698-701.
[12]	Liu K, Ji B, Zhang W, et al. Comparison of iodine-125 seed implantation and pancreaticoduodenectomy in the treatment of pancreatic cancer[J]. Int J Med Sci, 2014, 11(9): 893-896.
[13]	李会星, 史宪杰, 梁雨荣, 等. <sup>125</sup>I粒子植入治疗晚期胰腺癌术后胰瘘的危险因素[J]. 中华肝胆外科杂志, 2014, 20(12): 862-865. LI Huixing, SHI Xianjie, LIANG Yurong, et al. Risk factors of pancreatic fistula after <sup>125</sup>I particles implantation for advanced pancreatic carcinoma[J]. Chinese Journal of Hepatobiliary Surgery, 2014, 20(12): 862-865.
[14]	Kawai M, Hirono S, Okada K, et al. Randomized controlled trial of pancreaticojejunostomy versus stapler closure of the pancreatic stump during distal pancreatectomy to reduce pancreatic fistula[J]. Ann Surg, 2016, 264(1): 180-187.
[15]	杜义安, 俞炎平, 王实, 等. 内镜联合<sup>125</sup>I粒子植入在老年胰腺癌患者手术治疗中的应用[J]. 中华老年医学杂志, 2013, 32(4): 390-392. DU Yian, YU Yanping, WANG Shi, et al. Application of endoscopy combined with <sup>125</sup>I seed implantation in the pancreatic cancer surgery in elderly patients[J].Chinese Journal of Geriatrics, 2013, 32(4): 390-392.
[16]	王娟. 腹部肿瘤放射性粒子治疗技术[M]. 北京: 人民卫生出版社, 2014.
[17]	吴娟, 隋爱霞, 张宏涛, 等. CT引导下<sup>125</sup>I粒子治疗腹膜后恶性肿瘤穿刺路径分析[J]. 介入放射学杂志, 2015, 24(10): 902-905. WU Juan, SUI Aixia, ZHANG Hongtao, et al. CT-guided <sup>125</sup>I seed implantation for the treatment of retroperitoneal malignant tumors: analysis of puncturing approaches[J]. Journal of Interventional Radiology, 2015, 24(10): 902-905.
[18]	Huang MW, Liu SM, Zheng L, et al. A digital model individual template and CT-guided <sup>125</sup>I Seed implants for malignant tumors of the head and neck[J]. J Radiat Res, 2012, 53(6): 973-977.
[19]	Wu LL, Luo JJ, Yan ZP, et al. Comparative study of portal vein stent and TACE combined therapy with or without endovascular implantation of iodine-125 seeds strand for treating patients with hepatocellular carcinoma and main portal vein tumor thrombus[J]. Zhonghua Gan Zang Bing Za Zhi, 2012, 20(12): 915-919.
[20]	何闯, 刘云, 杨丽, 等. CT引导下<sup>125</sup>I粒子治疗腹膜后淋巴结转移瘤植入技巧[J]. 介入放射学杂志, 2015, 24(6): 534-536. HE Chuang, LIU Yun, YANG Li, et al. CT- guided <sup>125</sup>I seed implantation for retroperitoneal lymph node metastases: its technical points[J]. Journal of Interventional Radiology, 2015, 24(6): 534-536.
[21]	杨军, 关秀文, 韦炳邓, 等. 胃癌根治术后胃瘫综合征的治疗及危险因素分析[J]. 中国现代普通外科进展, 2012, 15(7): 578-579.
[22]	王俊杰, 修典荣, 冉维强, 等. 术中超声引导放射性<sup>125</sup>I粒子组织间植入治疗胰腺癌[J].中华放射肿瘤学杂志, 2007, 16(1): 34-37. WANG Junjie, XIU Dianrong, RAN Weiqiang, et al. Intraoperative ultrasound guided iodine-125 seed implantation for unresectable pancreatic carcinoma[J]. Chinese Journal of Radiation Oncology, 2007, 16(1): 34-37.
[23]	姚波, 王雅棣, 路娜, 等. 局部复发直肠癌超常规大分割同步放化疗疗效分析[J]. 中华放射医学与防护杂志, 2015, 35(8): 603-607. YAO Bo, WANG Yali, LU Na, et al. Outcomes for patients with locally recurrent rectal cancer treated with hypofractionated chemoradiotherapy without resection[J]. Chinese Journal of Radiological Medicine and Protection, 2015, 35(8): 603-607.
[24]	郭金友, 郑家平, 费伦, 等. CT引导下<sup>125</sup>I粒子植入治疗合并癌痛难治性恶性肿瘤[J]. 介入放射学杂志, 2016, 25(2): 141-144. GUO Jinyou, ZHENG Jiaping, FEI Lun, et al. CT-guided <sup>125</sup>I seed implantation for the treatment of refractory malignant tumor accompanied with cancerous pain[J]. Journal of Interventional Radiology, 2016, 25(2): 141-144.
[25]	郑家平, 邵国良, 罗君, 等. CT引导下<sup>125</sup>I粒子组织间植入治疗难治性肝癌[J]. 介入放射学杂志, 2015, 24(3): 260-264. ZHENG Jiaping, SHAO Guoliang, LUO Jun, et al. CT-guided <sup>125</sup>I seeds interstitial implantation for the refractory liver cancers ineffective to commonly used therapies[J]. Journal of Interventional Radiology, 2015, 24(3): 260-264.
[26]	郭宝明, 张治民. 胃镜下植入放射性碘-125粒子治疗晚期胃癌的疗效及安全性[J].现代中西医结合杂志, 2014, 23(27): 3004-3007.
[27]	Yao L, Jiang Y, Jiang P, et al. CT-guided permanent <sup>125</sup>I seed interstitial brachytherapy for recurrent retroperitoneal lymph node metastases after external beam radiotherapy[J]. Brachytherapy, 2015, 14(5): 662-669.
[28]	Gao F, Li C, Gu Y, et al. CT-guided <sup>125</sup>I brachytherapy for mediastinal metastatic lymph nodes recurrence from esophageal carcinoma: effectiveness and safety in 16 patients[J]. Eur J Radiol, 2013, 82(2): 70-75.
[29]	俞炎平, 江海涛, 姚征, 等. CT引导下经皮胰腺穿刺活检和组织间植入治疗的径路及安全性[J]. 中华肿瘤杂志, 2013, 35(8): 608-612. YU Yanping, JIANG Haitao, YAO Zheng, et al. Feasibility and safety of CT-guided percutaneous needle biopsy and subsequent iodine-125 seed interstitial implantation for pancreatic cancer[J]. Chinese Journal of Oncology, 2013, 35(8): 608-612.
[30]	Li WH, Dai ZY, Wan HG, et al. Endovascular implantation of iodine-125 seeds strand and portal vein stenting followed by transcatheter arterial chemoembolization combined therapy with sorafenib for hepatocellular carcinoma with main portal vein tumor thrombus[J]. Zhonghua Yi Xue Za Zhi, 2016, 96(23): 1838-1842.

Full-Text